Abstract
A large and growing proportion of CME (about 60% in the US3) is derived through commercial sponsorship, mainly by pharmaceutical companies. Responsibility for determining the legitimacy of commercially driven CME and its qualification for credits by the Canadian College of Family Physicians and the Royal College is delegated (by the 2 colleges) to the directors of CME at Canadian medical schools. The CME series in question were approved by the University of Calgary and then endorsed by the Canadian Medical Association and hosted on the CMA Web site.

This publication has 1 reference indexed in Scilit: